May 19, 2022
Voyager Therapeutics
Voyager Therapeutics’ TRACER™ Capsids Demonstrate Enhanced CNS Transduction Across Species; New Preclinical Results Bolster GBA1, Tau, SOD1 ALS Gene Therapy Programs
May 18, 2022
Ambys Medicines
Ambys Medicines Presents New Data Further Validating its Novel Liver Cell Replacement Therapy Platform at the ASGCT Annual Meeting
May 17, 2022
Nurix
Nurix Therapeutics Reports Dosing of First Patient in Phase 1 Clinical Trial of NX-5948, a Selective BTK Degrader, in Development for B-cell Leukemias and Lymphomas
May 16, 2022
Magenta Therapeutics
Magenta Therapeutics Reports First Quarter Financial Results, Early Clinical Observations From MGTA-117 Clinical Trial and Other Program Highlights
May 12, 2022
Rheos Medicines
Rheos Medicines CSO Dania Rabah to Deliver Keynote Address at AAPS National Biotechnology Conference